CRNO B — Cereno Scientific AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK880.87m
- SEK839.10m
Annual cashflow statement for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.3 | -16 | -16.3 | -27.7 | -48.1 |
| Depreciation | |||||
| Non-Cash Items | 1.97 | 0.974 | 0.228 | 0.156 | 2.48 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.11 | -1.12 | 2.88 | 8.87 | 8.7 |
| Change in Accounts Receivable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.4 | -16.1 | -13.1 | -18.6 | -36.9 |
| Capital Expenditures | -12 | -8.23 | -44.8 | -57.5 | -49.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.065 | -0.008 | — | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -12 | -8.24 | -44.8 | -57.5 | -49.3 |
| Financing Cash Flow Items | -12.6 | -4.93 | -4.24 | -3.12 | -15.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.3 | 64.3 | 81.6 | 53.6 | 106 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.9 | 39.9 | 23.6 | -22.6 | 20.1 |